ITGAM and head and neck cancer: In our recently published paper, it has been demonstrated that the investigated ITGAM SNP (-323G > A) may serve as a useful marker in the assessment of the risk of occurrence of nutritional disorders in head and neck cancer (HNC) patients undergoing radiotherapy (RT)14.